Increased serum myonectin and irisin levels with myonectin and FNDC5 expressions in polycystic ovary syndrome: a case control study

References

• Abali R, Temel Yuksel I, Yuksel MA, Bulut B, Imamoglu M, Emirdar V, et al. 2016. Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology 36:897–901.
   PubMed Web of Science ®Google Scholar
• Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. 2012. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468.
   PubMed Web of Science ®Google Scholar
• Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. 2016. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction 31:2841–2855.
   PubMed Web of Science ®Google Scholar
• Capurso C, Capurso A. 2012. From excess adiposity to insulin resistance: the role of free fatty acids. Vascular Pharmacology 57:91–97.
   PubMed Web of Science ®Google Scholar
• Celik C, Tasdemir N, Abali R, Bastu E, Yilmaz M. 2014. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study. Fertility and Sterility 101:1123–1128.e1.
   PubMed Web of Science ®Google Scholar
• Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, et al. 2013. Serum irisin levels in new-onset type 2 diabetes. Diabetes Research and Clinical Practice 100:96–101.
   PubMed Web of Science ®Google Scholar
• Demir I, Guler A. 2020. Association of decreased myonectin levels with metabolic and hormonal disturbance in polycystic ovary syndrome. Gynecological Endocrinology 36:947–950.
   PubMed Web of Science ®Google Scholar
• Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. 2012. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 97:28–38.e25.
   PubMed Web of Science ®Google Scholar
• Gibson-Helm M, Teede H, Dunaif A, Dokras A. 2017. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 102:604–612.
   PubMed Web of Science ®Google Scholar
• Group, Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25.
   Web of Science ®Google Scholar
• Kamiński M, Joanna K, Anna G, Justyna S, Marcin K, Lena B, et al. 2019. Myonectin serum concentration changes after short-term physical activity among young, healthy people. Medical Research Journal 4:41–45.
   Google Scholar
• Kishore U, Reid KB. 2000. C1q: structure, function, and receptors. Immunopharmacology 49:159–170.
   PubMed Web of Science ®Google Scholar
• Li L, Wang Q, Qin C. 2020. Serum myonectin is increased after laparoscopic sleeve gastrectomy. Annals of Clinical Biochemistry 57:360–364.
   PubMed Web of Science ®Google Scholar
• Li M, Yang M, Zhou X, Fang X, Hu W, Zhu W, et al. 2015. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 100:1485–1493.
   PubMed Web of Science ®Google Scholar
• Li Z, Yang YL, Zhu YJ, Li CG, Tang YZ, Ni CL, et al. 2019. Circulating serum myonectin levels in obesity and type 2 diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes 129:528–534.
   PubMed Web of Science ®Google Scholar
• Masaeli A, Nayeri H, Mirzaee M. 2019. Effect of metformin treatment on insulin resistance markers, and circulating irisin in women with Polycystic Ovarian Syndrome (PCOS). Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones et Metabolisme 51:575–579.
   PubMed Web of Science ®Google Scholar
• Otaka N, Shibata R, Ohashi K, Uemura Y, Kambara T, Enomoto T, et al. 2018. Myonectin is an exercise-induced myokine that protects the heart from ischemia-reperfusion injury. Circulation Research 123:1326–1338.
   PubMed Web of Science ®Google Scholar
• Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, et al. 2013. Circulating irisin in relation to insulin resistance and the metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism 98:4899–4907.
   PubMed Web of Science ®Google Scholar
• Peterson JM, Mart R, Bond CE. 2014. Effect of obesity and exercise on the expression of the novel myokines, Myonectin and Fibronectin type III domain containing 5. Peer J 2:e605.
   PubMed Web of Science ®Google Scholar
• Polyzos SA, Anastasilakis AD, Efstathiadou ZA, Makras P, Perakakis N, Kountouras J, et al. 2018. Irisin in metabolic diseases. Endocrine 2:260–274.
   Web of Science ®Google Scholar
• Rabiee F, Lachinani L, Ghaedi S, Nasr-Esfahani MH, Megraw TL, Ghaedi K. 2020. New insights into the cellular activities of Fndc5/Irisin and its signaling pathways. Cell & Bioscience 10:51.
   PubMed Web of Science ®Google Scholar
• Seldin MM, Wong GW. 2012. Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines. Adipocyte 1:200–202.
   PubMedGoogle Scholar
• Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW. 2012. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. The Journal of Biological Chemistry 287:11968–11980.
   PubMed Web of Science ®Google Scholar
• Shorakae S, Jona E, de Courten B, Lambert GW, Lambert EA, Phillips SE, et al. 2019. Brown adipose tissue thermogenesis in polycystic ovary syndrome. Clinical Endocrinology 3:425–432.
   Web of Science ®Google Scholar
• Sirmans SM, Pate KA. 2013. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clinical Epidemiology 6:1–13.
   PubMed Web of Science ®Google Scholar
• Toloza FJK, Mantilla-Rivas JO, Pérez-Matos MC, Ricardo-Silgado ML, Morales-Alvarez MC, Pinzón-Cortés JA, et al. 2018. Plasma levels of myonectin but not myostatin or fibroblast-derived growth factor 21 are associated with insulin resistance in adult humans without diabetes mellitus. Frontiers in Endocrinology 9:5.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang X-Y, Sun Y, Hou X-G, Chen L. 2018. Higher circulating irisin levels in patients with polycystic ovary syndrome:a meta-analysis. Gynecological Endocrinology 34:290–293.
   PubMed Web of Science ®Google Scholar
• Wang W, Guo Y, Zhang X, Zheng J. 2018. Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients. Clinical Endocrinology 89:474–480.
   PubMed Web of Science ®Google Scholar
• Zhang L, Fang X, Li L, Liu R, Zhang C, Liu H, et al. 2018. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome. Journal of Endocrinological Investigation 41:1401–1407.
   PubMed Web of Science ®Google Scholar